OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
24
Results
Show all
Save search
Copy query
Show results for
Unknown
(24)
Publication Date
Release Date
2020
(16)
2025
(3)
2024
(2)
2016
(1)
2014
(1)
2012
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations.
Not available
S-EPMC4212832
|
biostudies-literature
Cite
Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies.
Not available
S-EPMC3315211
|
biostudies-literature
Cite
Burden of disease scenarios by state in the USA, 2022-50: a forecasting analysis for the Global Burden of Disease Study 2021.
Not available
S-EPMC11715278
|
biostudies-literature
Cite
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.
Not available
S-EPMC7505971
|
biostudies-literature
Cite
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Not available
S-EPMC4835977
|
biostudies-literature
Cite
Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig.
Not available
S-EPMC7002414
|
biostudies-literature
Cite
Inferring structural variant cancer cell fraction.
Not available
S-EPMC7002525
|
biostudies-literature
Cite
Comprehensive molecular characterization of mitochondrial genomes in human cancers.
Not available
S-EPMC7058535
|
biostudies-literature
Cite
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.
Not available
S-EPMC7058534
|
biostudies-literature
Cite
Genomic footprints of activated telomere maintenance mechanisms in cancer.
Not available
S-EPMC7002710
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets